IE
TGTX icon

Israel Englander’s TG Therapeutics TGTX Stock Holding History

Israel Englander’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Sell
9,100
-29,200
-76% -$1.2M ﹤0.01% 4771
2026
Q1 		$1.27M Buy
+38,300
New +$1.14M ﹤0.01% 4208
2025
Q2 		– Sell
-10,000
Closed -$394K – 6323
2025
Q1 		$394K Buy
+10,000
New +$336K ﹤0.01% 4945
2024
Q1 		– Sell
-181,500
Closed -$3.1M – 6652
2023
Q4 		$3.1M Buy
+181,500
New +$2.11M ﹤0.01% 3214
2023
Q3 		– Sell
-101,400
Closed -$2.52M – 6561
2023
Q2 		$2.52M Sell
101,400
-103,000
-50% -$2.66M ﹤0.01% 3276
2023
Q1 		$3.07M Sell
204,400
-46,900
-19% -$712K ﹤0.01% 3028
2022
Q4 		$2.97M Buy
251,300
+51,300
+26% +$372K ﹤0.01% 3222
2022
Q3 		$1.18M Buy
200,000
+27,400
+16% +$180K ﹤0.01% 4193
2022
Q2 		$734K Sell
172,600
-127,400
-42% -$795K ﹤0.01% 4653
2022
Q1 		$2.85M Buy
300,000
+217,300
+263% +$2.51M ﹤0.01% 3543
2021
Q4 		$1.57M Buy
82,700
+42,700
+107% +$1.11M ﹤0.01% 3988
2021
Q3 		$1.33M Buy
+40,000
New +$1.24M ﹤0.01% 4367
2020
Q2 		– Sell
-100,000
Closed -$984K – 4594
2020
Q1 		$984K Sell
100,000
-350,000
-78% -$4.42M ﹤0.01% 2477
2019
Q4 		$5M Buy
+450,000
New +$3.42M 0.01% 1942
2019
Q2 		– Sell
-1,025,100
Closed -$8.24M – 4450
2019
Q1 		$8.24M Buy
+1,025,100
New +$5.54M 0.01% 1404

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Israel Englander's TGTX Position: Q2 2026 in Review

Israel Englander increased its TG Therapeutics (TGTX) stake by 122% in Q2 2026, buying an estimated $6.14M and bringing the position to 272,511 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #1892.

Israel Englander first reported a position in TGTX in Q3 2013 and has held it in 44 quarters since. The position peaked at $73.3M in Q4 2022. 426 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Israel Englander held 272,511 shares of TG Therapeutics worth $15M as of Q2 2026.
  • Israel Englander bought 149,924 TG Therapeutics shares in Q2 2026, an estimated $6.14M.
  • TG Therapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1892 holding.
  • Israel Englander first reported a position in TG Therapeutics in Q3 2013 and has held it in 44 quarters since.
  • Israel Englander's TG Therapeutics position peaked at $73.3M in Q4 2022.
  • 426 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.